CRONOS GROUP INC. Income (Loss) from Equity Method Investments
CRONOS GROUP INC. (CRON) reported Income (Loss) from Equity Method Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-02-26
- CRONOS GROUP INC. income (loss) from equity method investments for the quarter ending 2025-12-31 was $0.00.
- CRONOS GROUP INC. income (loss) from equity method investments for the quarter ending 2025-09-30 was $0.00.
- CRONOS GROUP INC. income (loss) from equity method investments for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. income (loss) from equity method investments for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. income (loss) from equity method investments for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CRONOS GROUP INC. income (loss) from equity method investments for fiscal 2024 was $2.37M, a 49.40% increase from fiscal 2023.
- CRONOS GROUP INC. income (loss) from equity method investments for fiscal 2023 was $1.58M, a 49.17% decline from fiscal 2022.
- CRONOS GROUP INC. income (loss) from equity method investments for fiscal 2022 was $3.11M.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $917.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $917.00K derived: sum of 3 quarters · filed 2026-02-26 | $2.37M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $917.00K derived: sum of 2 quarters · filed 2025-11-06 | $2.37M 10-Q · filed 2025-11-06 | $3.12M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $917.00K 10-Q · filed 2025-08-07 | $2.37M 10-Q · filed 2025-08-07 | $3.12M derived: sum of 3 quarters · filed 2026-02-26 | $4.17M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.45M 10-Q · filed 2025-05-08 | $2.20M derived: sum of 2 quarters · filed 2026-02-26 | $3.26M derived: sum of 3 quarters · filed 2026-02-26 | $3.53M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $752.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.81M derived: sum of 2 quarters · filed 2026-02-26 | $2.08M derived: sum of 3 quarters · filed 2026-02-26 | $1.58M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.06M 10-Q · filed 2024-11-12 | $1.33M derived: sum of 2 quarters · filed 2024-11-12 | $831.00K 10-Q · filed 2024-11-12 | -$133.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $270.00K 10-Q · filed 2024-08-08 | -$226.00K 10-Q · filed 2024-08-08 | -$1.19M derived: sum of 3 quarters · filed 2025-02-27 | -$2.31M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$496.00K 10-Q · filed 2024-05-09 | -$1.46M derived: sum of 2 quarters · filed 2025-02-27 | -$2.58M derived: sum of 3 quarters · filed 2025-02-27 | $2.62M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$964.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$2.08M derived: sum of 2 quarters · filed 2025-02-27 | $3.11M derived: sum of 3 quarters · filed 2025-02-27 | $3.11M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$1.12M 10-Q · filed 2023-11-08 | $4.08M derived: sum of 2 quarters · filed 2023-11-08 | $4.08M 10-Q · filed 2023-11-08 | $1.94M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $5.20M 10-Q · filed 2023-08-08 | $5.20M 10-Q · filed 2023-08-08 | $3.06M derived: sum of 3 quarters · filed 2024-02-29 | $1.64M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | -$2.14M derived: sum of 2 quarters · filed 2024-02-29 | -$3.56M derived: sum of 3 quarters · filed 2024-02-29 | -$4.67M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$3.56M derived: sum of 2 quarters · filed 2024-02-29 | -$4.67M derived: sum of 3 quarters · filed 2024-02-29 | -$6.31M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$1.41M 10-Q · filed 2022-11-07 | -$2.53M derived: sum of 2 quarters · filed 2022-11-07 | -$4.17M 10-Q · filed 2022-11-07 | -$5.39M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$1.11M 10-Q · filed 2022-08-09 | -$2.76M 10-Q · filed 2022-08-09 | -$3.98M derived: sum of 3 quarters · filed 2023-02-28 | -$5.30M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$1.64M 10-Q · filed 2022-05-10 | -$2.86M derived: sum of 2 quarters · filed 2023-02-28 | -$4.19M derived: sum of 3 quarters · filed 2023-02-28 | -$4.98M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$2.54M derived: sum of 2 quarters · filed 2023-02-28 | -$3.34M derived: sum of 3 quarters · filed 2023-02-28 | -$4.51M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$1.33M 10-Q · filed 2022-02-18 | -$2.12M derived: sum of 2 quarters · filed 2022-02-18 | -$3.29M 10-Q · filed 2022-02-18 | -$3.80M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$794.00K 10-Q/A · filed 2022-02-18 | -$1.97M 10-Q/A · filed 2022-02-18 | -$2.47M derived: sum of 3 quarters · filed 2022-03-01 | -$3.04M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$1.17M 10-Q · filed 2021-05-07 | -$1.68M derived: sum of 2 quarters · filed 2022-03-01 | -$2.24M derived: sum of 3 quarters · filed 2022-03-01 | -$2.98M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$1.07M derived: sum of 2 quarters · filed 2022-03-01 | -$1.81M derived: sum of 3 quarters · filed 2022-03-01 | -$2.01M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$565.00K 10-Q · filed 2020-11-05 | -$1.31M derived: sum of 2 quarters · filed 2020-11-05 | -$1.50M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$741.00K 10-Q · filed 2020-08-06 | -$939.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$198.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | -$723.00K 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $127.00K 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |